Fixocard 50 Tablet
by Incepta Pharmaceuticals Ltd
৳8.00
Empazin 10
Delta Pharma Limited
1 Strip = 10 Pcs
৳150.00
1 Box = 3 Strips
৳450.00
Dosage: Empagliflozin 10mg
Form: Tablet
Generic name(s): Empagliflozin 10mg
Available (pcs): 20
Prescription required: No
Buy Empazin 10 Tablet: View Uses, Price, Side Effects & Dosage - osudpotro
Empazin 10 Tablet from Delta Pharmaceuticals & Generic is Empagliflozin 10mg. Empagliflozin is indicated in- As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Indications of Empazin 10 Tablet
Empagliflozin is indicated in:
- As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Pharmalogy of Empazin 10 Tablet
Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. The SGLT2 cotransporter is responsible for the reabsorption of glucose from the renal glomerular filtrate. The diabetic effect of SGLT2 inhibition reduces renal absorption and lowers the kidney's glucose threshold, leading to increased glucose excretion. In addition, it also helps reduce high blood sugar levels, aids in weight loss, and lowers blood pressure.
Dosage & Administration of Empazin 10 Tablet
The recommended dose of Empagliflozin is 10 mg once daily, taken in the morning, with or without food. In patients tolerating Empagliflozin, the dose may be increased to 25 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of Empagliflozin is recommended.
Interaction of Empazin 10 Tablet
Diuretics: Enpagliflozin combined with diuretics causes an increase in urine production.
Insulin or insulin secretagogue: Enpagliflozin combined with insulin or insulin secretagogue may increase the risk of hypoglycemia.
Positive urine glucose test: It is not recommended to monitor blood glucose control through a urine glucose test in patients taking SGLT2 inhibitors, because SGLT2 inhibitors increase urine glucose excretion and result in a positive urine glucose test result. Use alternative methods to control blood sugar control.
Interferes with the 1.5 anhydroglucitol (1.5AG) test: The 1.5AG test is not recommended for monitoring blood glucose control because the 1.5AG measurement is not reliable when assessing glucose control in blood in patients taking SGLT2 inhibitors. Use alternative methods to control blood sugar control.
Contraindications
Empagliflozin is contraindicated in patients with a history of severe hypersensitivity, severe renal impairment, end-stage renal disease or dialysis to Empagliflozin or any of its components.
Side Effects of Empazin 10 Tablet
The most common adverse reactions associated with empagliflozin are urinary tract infections and female genital fungal infections. Other common side effects include dehydration, low blood pressure, weakness, dizziness, and increased thirst.
Pregnancy & Lactation
There are no adequate and well-controlled studies of empagliflozin in pregnant women. Empagliflozin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not clear whether empagliflozin is excreted in human milk. its use is not recommended during lactation.
Precautions & Warnings
It is recommended to regularly assess renal function before and after starting to use empagliflozin. Empagliflozin should not be started for patients with eGFR lower than 45 ml / min / 1.73 m2. Patients with eGFR greater than or equal to 45 ml/min/1.73 m2 do not need to adjust the dose.
Therapeutic Class
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children.
Pharmaceuticals name of Empazin 10 Tablet
Generic of Empazin 10 Tablet
